Intellectual Property of Psychedelics for Addiction Treatment: Enabling Access and Protecting Innovation Opportunities Through Preserving the Public Domain.

As the field of psychedelics approaches this critical inflection point of FDA decisions, it is imperative for all stakeholders - including university investigators, academic and commercial patent seekers, and policy makers - to utilize available tools for determining prior knowledge. Maintaining an informed awareness of legal patent eligibility and limitations is crucial for establishing an ethical patent landscape and ensuring subsequent access to these potential life-altering psychedelic therapeutics for addiction.